Shire plc, SHPG is in the exchange NASDAQ and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in Ireland, Shire plc, SHPG has a market cap of 58847.71. Since its IPO date on the 3/25/1998, Shire plc, SHPG performance year to date is -3.35%. Today Shire plc, SHPG has gained 0.71%, with a current price of 198.71.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 20.70%. The management of the company have seen the company have a payout ratio of 7.40%. Return of assets are at 3.10%, with return on investment at 12.00%.
In terms of debt levels and profit levels, Shire plc, SHPG is seeing a long-term debt/equity of 0.72. While Total debt/equity is 0.81. With a profit margin of 14.90%, this is combined with a gross margin of 85.10%, and operating margin of 21.90%. Shire plc ability to meet debt levels, with a current ratio of 1.4, while the quick ratio is 0.6.
For the last year Shire plc, SHPG has seen a EPS growth of -59.40%. A performance for the year of -20.65%. The 52-week high is -21.10%, and the 52-week low is 35.19%. The average volume for Shire plc, SHPG is 353389.
With a target price of *TBA, can Shire plc, SHPG reach this target? Looking at the value indicators of Shire plc, SHPG. Shire plc has a P/E of 29.24 and a forward P/E of 13.05. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.86. Shire plc also has a P/S and a P/B of 8.87 and 1.51 respectively. For P/cash, Shire plc has a value of 84.87, while it is *TBA for P/free cash flow.
At the current price of 198.71, Shire plc has a dividend yield of 0.41%. We see a return on equity of 6.70%.
Looking more long-term Shire plc, is projected to get an EPS growth for the next five years of 15.70%. In the short-term an EPS growth of 18.64% in the next year is forecasted. This is after a EPS growth of -59.40% for this year and for the last five years a 16.50% growth has been seen.